相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Elevated expression of exogenous RAD51 enhances the CRISPR/Cas9-mediated genome editing efficiency
Seo Jung Park et al.
BMB REPORTS (2023)
α-Kleisin subunit of cohesin preserves the genome integrity of embryonic stem cells
Seobin Yoon et al.
BMB REPORTS (2023)
Human topoisomerases and their roles in genome stability and organization
Yves Pommier et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2022)
RAD51 is a druggable target that sustains replication fork progression upon DNA replication stress
Sonia Feu et al.
PLOS ONE (2022)
RAD51 protects human cells from transcription-replication conflicts
Rahul Bhowmick et al.
MOLECULAR CELL (2022)
The Kleisin Subunits of Cohesin are Involved in the Fate Determination of Embryonic Stem Cells
Young Eun Koh et al.
MOLECULES AND CELLS (2022)
Meiosis-specific cohesin complexes display essential and distinct roles in mitotic embryonic stem cell chromosomes
Eui-Hwan Choi et al.
GENOME BIOLOGY (2022)
Control of replication stress and mitosis in colorectal cancer stem cells through the interplay of PARP1, MRE11 and RAD51
Gwenola Manic et al.
CELL DEATH AND DIFFERENTIATION (2021)
DNA Repair Pathways in Cancer Therapy and Resistance
Lan-ya Li et al.
FRONTIERS IN PHARMACOLOGY (2021)
Maintenance of genome integrity and active homologous recombination in embryonic stem cells
Eui-Hwan Choi et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2020)
5-FU promotes stemness of colorectal cancer via p53-mediated WNT/β-catenin pathway activation
Yong-Hee Cho et al.
NATURE COMMUNICATIONS (2020)
The mutational pattern of homologous recombination-related (HRR) genes in Chinese colon cancer and its relevance to immunotherapy responses
Pei Zhou et al.
Aging-US (2020)
Regulation and pharmacological targeting of RAD51 in cancer
McKenzie K. Grundy et al.
NAR CANCER (2020)
Comprehensive review of targeted therapy for colorectal cancer
Yuan-Hong Xie et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Targeting Topoisomerase I in the Era of Precision Medicine
Anish Thomas et al.
CLINICAL CANCER RESEARCH (2019)
A Multifunctional Nanotherapy for Targeted Treatment of Colon Cancer by Simultaneously Regulating Tumor Microenvironment
Qixiong Zhang et al.
THERANOSTICS (2019)
Combined Ectopic Expression of Homologous Recombination Factors Promotes Embryonic Stem Cell Differentiation
Eui-Hwan Choi et al.
MOLECULAR THERAPY (2018)
RPA and RAD51: fork reversal, fork protection, and genome stability
Kamakoti P. Bhat et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2018)
RPA and RAD51: fork reversal, fork protection, and genome stability
Kamakoti P. Bhat et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2018)
RAD51 as a potential surrogate marker for DNA repair capacity in solid malignancies
Mariam Gachechiladze et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Cellular Dynamics of Rad51 and Rad54 in Response to Postreplicative Stress and DNA Damage in HeLa Cells
Eui-Hwan Choi et al.
MOLECULES AND CELLS (2017)
Meiotic Knockdown and Complementation Reveals Essential Role of RAD51 in Mouse Spermatogenesis
Jieqiong Dai et al.
CELL REPORTS (2017)
The Homologous Recombination Machinery Orchestrates Post-replication DNA Repair During Self-renewal of Mouse Embryonic Stem Cells
Eui-Hwan Choi et al.
SCIENTIFIC REPORTS (2017)
First-line chemotherapy for mCRC-a review and evidence-based algorithm
Chiara Cremolini et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2015)
Caffeine inhibits gene conversion by displacing Rad51 from ssDNA
Michael Tsabar et al.
NUCLEIC ACIDS RESEARCH (2015)
The effect of caffeine on cisplatin-induced apoptosis of lung cancer cells
Gan Wang et al.
EXPERIMENTAL HEMATOLGY & ONCOLOGY (2015)
The BRCA2 gene is a potential molecular target during 5-fluorouracil therapy in human oral cancer cells
Yosuke Nakagawa et al.
ONCOLOGY REPORTS (2014)
Rad51 Regulates Cell Cycle Progression by Preserving G2/M Transition in Mouse Embryonic Stem Cells
Sang-Wook Yoon et al.
STEM CELLS AND DEVELOPMENT (2014)
RAD51 overexpression is a negative prognostic marker for colorectal adenocarcinoma
Pierre Tennstedt et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Caffeine suppresses homologous recombination through interference with RAD51-mediated joint molecule formation
Alex N. Zelensky et al.
NUCLEIC ACIDS RESEARCH (2013)
Biomarker-guided repurposing of chemotherapeutic drugs for cancer therapy: a novel strategy in drug development
Jan Stenvang et al.
FRONTIERS IN ONCOLOGY (2013)
Homologous recombination and its regulation
Lumir Krejci et al.
NUCLEIC ACIDS RESEARCH (2012)
TOP1 gene copy numbers in colorectal cancer samples and cell lines and their association to in vitro drug sensitivity
Maria Unni Romer et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Caffeine Promotes Ultraviolet B-induced Apoptosis in Human Keratinocytes without Complete DNA Repair
Weinong Han et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
DNA Topoisomerases and Their Poisoning by Anticancer and Antibacterial Drugs
Yves Pommier et al.
CHEMISTRY & BIOLOGY (2010)
Novel Approaches for Targeting Thymidylate Synthase To Overcome the Resistance and Toxicity of Anticancer Drugs
Divita Garg et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Overexpression of RAD51 suppresses recombination defects: a possible mechanism to reverse genomic instability
David Schild et al.
NUCLEIC ACIDS RESEARCH (2010)
5-Fluorouracil and its active metabolite FdUMP cause DNA damage in human SW620 colon adenocarcinoma cell line
Renata Matuo et al.
JOURNAL OF APPLIED TOXICOLOGY (2009)
Homologous recombination in DNA repair and DNA damage tolerance
Xuan Li et al.
CELL RESEARCH (2008)
Genome instability: a mechanistic view of its causes and consequences
Andres Aguilera et al.
NATURE REVIEWS GENETICS (2008)
DNA repair pathways as targets for cancer therapy
Thomas Helleday et al.
NATURE REVIEWS CANCER (2008)
ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage
Shuhei Matsuoka et al.
SCIENCE (2007)
The enigmatic effects of caffeine in cell cycle and cancer
Ann M. Bode et al.
CANCER LETTERS (2007)
Topoisomerase I inhibitors: camptothecins and beyond
Yves Pommier
NATURE REVIEWS CANCER (2006)
Clinical development of gene therapy for colorectal cancer
D Kerr
NATURE REVIEWS CANCER (2003)
5-Fluorouracil: Mechanisms of action and clinical strategies
DB Longley et al.
NATURE REVIEWS CANCER (2003)
Irinotecan: mechanisms of tumor resistance and novel strategies for modulating its activity
Y Xu et al.
ANNALS OF ONCOLOGY (2002)
How nucleotide excision repair protects against cancer
EC Friedberg
NATURE REVIEWS CANCER (2001)
Developmental regulation of DNA-topoisomerases during Drosophila embryogenesis
MJ Gemkow et al.
EXPERIMENTAL CELL RESEARCH (2001)
Conversion of topoisomerase 1 cleavage complexes on the leading strand of ribosomal DNA into 5′-phosphorylated DNA double-strand breaks by replication runoff
D Strumberg et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
分享论文
